Biotechnology Jobs

CSL · Maidenhead

Leads strategic sourcing and evaluation of late-stage external clinical assets in Immunology, from Phase 2 through marketed drugs, as the senior S&E leader within the Therapy Area Leadership Team. Drives proactive sourcing, cross-functional due diligence, and KOL engagement, partnering with BD to advance high-priority opportunities through negotiation and deal close.

GSK · London

Provides advanced scientific expertise in safety evaluation and risk management for key oncology assets in clinical development, leading signal detection, benefit-risk assessment and regulatory safety submissions. Represents the Safety Evaluation & Risk Management function on cross-functional clinical matrix and project teams, escalating emerging safety issues to senior governance. Mentors junior staff and partners with Safety Physicians to shape long-term safety strategy.

GSK · Poznań, Poland · PLN 525,750 – PLN 876,250 pa

Provides advanced scientific expertise in safety evaluation and risk management for key oncology assets in clinical development, leading signal detection, benefit-risk assessment and regulatory safety submissions. Represents SERM on cross-functional clinical matrix teams, escalates emerging safety issues to governance bodies and mentors junior staff within a global matrix environment.

Isomorphic Labs · Cambridge, United States

Lead and execute the translational medicine strategy for an oncology portfolio, ensuring clinical biomarker assay readiness and data delivery to inform mechanism of action, resistance and future indications. Serve as a core program team member and cancer biology expert, collaborating with AI and computational biology teams to build innovative biomarker analysis tools and advance companion diagnostics.

Recursion · Remote Opportunity - United States · US$261,800 – US$346,060 pa

Lead clinical pharmacology and pharmacometrics strategy across a portfolio of rare disease and oncology programs, serving as the clinical pharmacology lead and regulatory representative. Oversee modeling and simulation (population PK, PK-PD, exposure-response) and provide pharmacology input on Phase 1-3 study designs. Work cross-functionally with clinical, translational and discovery teams in an end-to-end drug development environment.

Relation Therapeutics · London

Develops and benchmarks machine learning models for DNA sequence, regulatory elements and genetic variation, including variant effect prediction and representation learning. Integrates sequence-derived representations with transcriptomic, epigenomic and perturbational data to uncover disease mechanisms and support target prioritisation, working within the interdisciplinary Rosalind team.

Autolus · US - East Coast

Leads identification, evaluation and execution of strategic partnerships, licensing, M&A and co-development deals, from sourcing through due diligence, structuring and closing. Represents the company to biotech, pharma and academic partners, monitors competitive and market dynamics, and advises executive leadership on external innovation strategy post-launch.

Isomorphic Labs · Cambridge, United States

Lead end-to-end clinical trial material planning, vendor management, packaging, labeling, inventory and global distribution for an AI-first drug discovery company. Act as the clinical supply authority within a lean Pharmaceutical Sciences & CMC team, building scalable systems and vendor networks while partnering closely with Clinical Operations and CROs.

Vertex Pharmaceuticals · London

Oversees cell and gene therapy Contract Manufacturing Organizations as the primary on-site point of contact, providing operational, quality and technical oversight of cGMP commercial supply. Acts as a Person-in-Plant and SME within the Virtual Plant Team, managing deviations, change controls, batch data and supplier governance, with up to 50% travel and shift coverage for critical process steps.

Autolus · Stevenage

Accountable for onboarding and ongoing performance management of apheresis and treatment centres supporting clinical and commercial CAR T-cell therapies across the UK and Rest of World. Serves as the technical operations single point of contact, conducting site assessments, training centre staff, supporting quality systems and deviations, and managing process change rollouts. Involves up to 50% travel and possible management of contract employees.

SRG · Darlington · £65,000 – £85,000 pa

Lead multidisciplinary operational teams across two sites, covering operations, engineering, facilities and site services. Drive continuous improvement, GMP and H&S compliance, facilities management, budgets and capital projects supporting biologics, RNA and medicines manufacturing. Senior leadership role shaping facility strategy and operational capability.

Bicycle Therapeutics · Cambridge

Operational backbone of R&D Quality, administering and optimising a validated eQMS (Veeva, TrackWise, Dot Compliance) for GxP document control, training matrices, deviation/CAPA tracking and inspection readiness. Supports FDA, MHRA and EMA inspections and works across clinical, non-clinical and pharmacovigilance teams.

Moderna · London

Lead CMC regulatory strategy for UK-manufactured and UK-licensed mRNA products across development, registration and post-approval lifecycle. Act as primary point of contact with the MHRA, oversee submissions and manufacturing change assessments, and shape global regulatory approaches across cross-functional matrix teams.

Evotec · Abingdon

Owns Evotec's in silico therapeutics design capability, uniting computational chemistry, generative and modality design (small molecules, peptides, protein engineering, degraders, molecular glues) and predictive ADMET/safety under one mandate. A newly created unit within the In Silico & AI group with an explicit build mandate: set technical vision, grow a multi-site team, and industrialise repeatable, benchmarked methods across partner programmes.

Evotec · Abingdon

Acts as the single front door between Global Biology Operations and the In Silico & AI organisation, owning demand, the in silico roadmap and delivery orchestration across computational biology, bioinformatics and AI teams. Focuses on Disease-to-Target and applying the proprietary E.MPD multi-omics resource to target identification, validation and patient stratification, while evidencing value and supporting client proposals.